Literature DB >> 11207277

The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells.

J S Navratil1, S C Watkins, J J Wisnieski, J M Ahearn.   

Abstract

Complement protein C1q is required to maintain immune tolerance. The molecular mechanism responsible for this link has not been determined. We have previously demonstrated that C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes, suggesting that it may participate in clearance of self Ags generated during programmed cell death. Here, we demonstrate that C1q also binds directly to apoptotic blebs of vascular endothelial cells and PBMC. These apoptotic cells are recognized by the globular heads of C1q, which bind specifically to the surface blebs, and deposition increases as the blebs mature on the cell surface. These observations suggest that C1q may participate in the clearance of apoptotic cells from the circulation and from the walls of the vascular lumen. The interaction of surface blebs with the globular heads of C1q suggests that surface blebs may be capable of directly activating the classical pathway of complement under certain circumstances, generating C4- and C3-derived ligands for receptors such as CR1, CR2, CR3, and CR4. Appropriate recognition of apoptotic cells by C1q and targeted clearance of the molecular contents of surface blebs to complement receptors may be critical for the maintenance of immune tolerance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207277     DOI: 10.4049/jimmunol.166.5.3231

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus.

Authors:  J S Navratil; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 2.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

Review 3.  The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?

Authors:  Christopher D Gregory; Andrew Devitt
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

Review 4.  Ectosomes as immunomodulators.

Authors:  Salima Sadallah; Ceylan Eken; Jürg A Schifferli
Journal:  Semin Immunopathol       Date:  2010-12-07       Impact factor: 9.623

5.  Defining a polymethine dye for fluorescence anisotropy applications in the near-infrared spectral range.

Authors:  Tiffany P Gustafson; Qian Cao; Samuel Achilefu; Mikhail Y Berezin
Journal:  Chemphyschem       Date:  2012-02-02       Impact factor: 3.102

Review 6.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

7.  Crystal structure of zebrafish complement 1qA globular domain.

Authors:  Hongyu Yuan; Rong Chen; Mansoor Tariq; Yanjie Liu; Yaping Sun; Chun Xia
Journal:  Protein Sci       Date:  2016-09-13       Impact factor: 6.725

Review 8.  Complement receptors and the shaping of the natural antibody repertoire.

Authors:  V Michael Holers
Journal:  Springer Semin Immunopathol       Date:  2004-12-22

9.  Red blood cell age and potentiation of transfusion-related pathology in trauma patients.

Authors:  Jordan A Weinberg; Scott R Barnum; Rakesh P Patel
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

10.  Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Vinay K Bhatia; Sheng Yun; Viola Leung; David C Grimsditch; G Martin Benson; Marina B Botto; Joseph J Boyle; Dorian O Haskard
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.